Article Text

PDF
Pulmonary rehabilitation, physical activity, respiratory failure and palliative respiratory care
  1. Martijn A Spruit1,2,3,
  2. Carolyn L Rochester4,5,
  3. Fabio Pitta6,
  4. Klaus Kenn7,8,
  5. Annemie M W J Schols3,
  6. Nicholas Hart9,10,
  7. Emiel F M Wouters2,3,
  8. Stefano Nava11,
  9. Michael Dreher12,
  10. Daisy J A Janssen2,13,
  11. Miriam J Johnson14,
  12. Randall J Curtis15,16,
  13. Manuel Sastry17,
  14. Frits M E Franssen2,3
  1. 1REVAL - Rehabilitation Research Center, BIOMED - Biomedical Research Institute, Faculty of Rehabilitation Sciences, Hasselt University, Diepenbeek, Belgium
  2. 2Department of Research and Education, CIRO, Horn, The Netherlands
  3. 3Department of Respiratory Medicine, Maastricht University Medical Centre (MUMC+), NUTRIMSchool of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands
  4. 4Section of Pulmonary and Critical Care, Yale University School of Medicine, New Haven, Connecticut, USA
  5. 5VA Connecticut Healthcare System, West Haven, CT, United States
  6. 6Department of Physiotherapy, Laboratory of Research in Respiratory Physiotherapy, Londrina, Brazil
  7. 7Department of Respiratory Medicine and Pulmonary Rehabilitation, Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee, Germany
  8. 8Department of Pulmonary Rehabilitation, University of Marburg, Marburg, Germany
  9. 9Lane Fox Respiratory Service, Guy's & St Thomas' NHS Foundation Trust, London, UK
  10. 10Lane-Fox Clinical Respiratory Physiology Research Centre, Guy’s and St Thomas’ NHS Trust, St Thomas’ Hospital, London, United Kingdom
  11. 11Alma Mater University, Dept. of Clinical, Integrated and Experimental Medicine (DIMES), Respiratory and Critical Care Unit, S. Orsola-Malpighi Hospital Bologna, Bologna, Italy
  12. 12Pneumology, Universitatsklinikum Aachen, Aachen, Germany
  13. 13Centre of Expertise for Palliative Care, MUMC+, Maastricht, The Netherlands
  14. 14Wolfson Palliative Care Research Centre, Hull York Medical School, The University of Hull, Hull, UK
  15. 15Pulmonary and Critical Care Medicine, University of Washington, Seattle, Washington, USA
  16. 16Cambia Palliative Care Center of Excellence, University of Washington, Seattle, United States
  17. 17Academic Sleep Center, CIRO, Horn, The Netherlands
  1. Correspondence to Prof Martijn A Spruit, Program Development Centre, CIRO, Horn 6085 NM, The Netherlands; martijnspruit{at}ciro-horn.nl

Abstract

The CIRO Academy in Horn (the Netherlands) organised a 2-day meeting to present and discuss the studies published in 2017 pertaining to key priority areas of respiratory and critical care medicine. This review summarises studies focussing on pulmonary rehabilitation and exercise training, physical activity, chronic respiratory failure and palliative respiratory care published in 2017.

  • exercise
  • pulmonary rehabilitation
  • palliative care
  • long-term oxygen therapy

Statistics from Altmetric.com

Footnotes

  • Correction notice This article has been corrected since it was published Online First. The middle initials were updated for the authors: Carolyn L Rochester, Emiel F M Wouters, Randall J Curtis and Frits M E Franssen.

  • Contributors Drafting of specific parts of the text: MAS, CLR, FP, KK, AMWJS, NH, EFMW, SN, MD, DJAJ, MJJ, RJC, MS and FMEF; planning and supervision of the work: MAS; critical revision of the text for important intellectual content: MAS, CLR, FP, KK, AMWJS, NH, EFMW, SN, MD, DJAJ, MJJ, RJC, MS and FMEF. MAS is responsible for the overall content as guarantor. All authors approved the version published.

  • Funding CIRO’s International Year in Review 2017 was endorsed by the European Respiratory Society and financially supported by AstraZeneca, GSK, Novartis, TEVA, ResMed, CareFusion and the Netherlands Respiratory Society.

  • Competing interests JRC, MD, MJJ, KK, SN, FP, MS, CLR, AMWJS and MAS have nothing to disclose. MD reports personal fees from Philips, ResMed, Weinmann, Heinen und Löwenstein, Fisher and grants from ResMed, outside the submitted work. FMEF reports personal fees from AstraZeneca, Chiesi, GlaxoSmithKline, Boehringer Ingelheim, Novartis and TEVA, outside the submitted work. NH is on the Pulmonary Research Advisory Board for Philips. NH’s research group has received unrestricted grants (managed by Guy’s) and Philips-Respironics is contributing to the development of the MYOTRACE technology. DJAJ reports personal fees from AstraZeneca, Novartis, Boehringer Ingelheim, GlaxoSmithKline and Mayne Pharma, outside the submitted work.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.